Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer

Head Neck Pathol. 2024 Mar 8;18(1):16. doi: 10.1007/s12105-024-01614-9.

Abstract

With the advent of molecular immunohistochemistry and next generation sequencing, Switch/sucrose non-fermentable (SWI/SNF) chromatin remodeling complex altered tumors have gained recognition recently. SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily B member 1 (SMARCB1) and SMARCA4 are the primary SWI/SNF components altered in several recently described undifferentiated malignancies in head and neck region with predilection for paranasal sinuses in SMARCB1-deficient tumors and nasal cavity in SMARCA4-deficient tumors. However, to the best of our knowledge, SMARCA4-deficient tumors of the oropharynx have not been described. We present an unusual case of SMARCA4-deficient carcinoma of the oropharynx (palatine tonsil) which is the first case in the literature, expanding the topographic distribution of SMARCA4-deficient tumors in the head and neck region and emphasizing the importance of BRG1 as an essential immunohistochemical marker for the diagnosis of this distinct entity.

Keywords: BRG1; Oropharynx; SMARCA4; SW1/SNF.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma* / pathology
  • DNA Helicases / genetics
  • Head and Neck Neoplasms* / diagnosis
  • Humans
  • Neck / pathology
  • Nuclear Proteins / genetics
  • Transcription Factors / genetics

Substances

  • Biomarkers, Tumor
  • SMARCA4 protein, human
  • DNA Helicases
  • Nuclear Proteins
  • Transcription Factors